BillionToOne raises $273.1m in IPO, becoming a public company despite the US government shutdown. Shares were sold at $60 each, resulting in a $2.6bn valuation. Revenues doubled in 2024 to $153m, driven by prenatal testing. The medtech IPO season continues with more expected in 2026.

Read more at Yahoo Finance: BillionToOne raises $273.1m in IPO